Suppr超能文献

相似文献

3
The presence of p47phox in liver parenchymal cells is a key mediator in the pathogenesis of alcoholic liver steatosis.
Alcohol Clin Exp Res. 2012 Aug;36(8):1397-406. doi: 10.1111/j.1530-0277.2012.01739.x. Epub 2012 Feb 29.
5
Protein tyrosine phosphatase 1b deficiency protects against hepatic fibrosis by modulating nadph oxidases.
Redox Biol. 2019 Sep;26:101263. doi: 10.1016/j.redox.2019.101263. Epub 2019 Jun 29.
6
Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation.
PLoS One. 2015 Jul 29;10(7):e0129743. doi: 10.1371/journal.pone.0129743. eCollection 2015.
7
Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice.
Alcohol Clin Exp Res. 2011 Aug;35(8):1509-18. doi: 10.1111/j.1530-0277.2011.01487.x. Epub 2011 Apr 4.
8
Loss of functional NADPH oxidase 2 protects against alcohol-induced bone resorption in female p47phox-/- mice.
Alcohol Clin Exp Res. 2014 Mar;38(3):672-82. doi: 10.1111/acer.12305. Epub 2013 Nov 20.
9
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review.
Cell Biochem Funct. 2018 Aug;36(6):292-302. doi: 10.1002/cbf.3351. Epub 2018 Jul 20.
10
Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in vivo.
Gastroenterology. 2010 Oct;139(4):1375-84. doi: 10.1053/j.gastro.2010.05.074. Epub 2010 Jun 1.

引用本文的文献

2
NOX as a Therapeutic Target in Liver Disease.
Antioxidants (Basel). 2022 Oct 16;11(10):2038. doi: 10.3390/antiox11102038.
3
Loss of heat shock factor 1 promotes hepatic stellate cell activation and drives liver fibrosis.
Hepatol Commun. 2022 Oct;6(10):2781-2797. doi: 10.1002/hep4.2058. Epub 2022 Aug 9.
4
Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4-Dependent ROS.
Oxid Med Cell Longev. 2022 Jan 5;2022:9938392. doi: 10.1155/2022/9938392. eCollection 2022.
5
6
Nanodrug with ROS and pH Dual-Sensitivity Ameliorates Liver Fibrosis via Multicellular Regulation.
Adv Sci (Weinh). 2020 Feb 14;7(7):1903138. doi: 10.1002/advs.201903138. eCollection 2020 Apr.
7
Mechanisms of liver fibrosis and its role in liver cancer.
Exp Biol Med (Maywood). 2020 Jan;245(2):96-108. doi: 10.1177/1535370219898141. Epub 2020 Jan 10.
9
NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
Gastroenterology. 2019 Mar;156(4):1156-1172.e6. doi: 10.1053/j.gastro.2018.11.019. Epub 2018 Nov 13.
10
NADPH Oxidase Signaling Pathway Mediates Mesenchymal Stem Cell-Induced Inhibition of Hepatic Stellate Cell Activation.
Stem Cells Int. 2018 May 10;2018:1239143. doi: 10.1155/2018/1239143. eCollection 2018.

本文引用的文献

1
Kupffer cells in non-alcoholic fatty liver disease: the emerging view.
J Hepatol. 2009 Jul;51(1):212-23. doi: 10.1016/j.jhep.2009.03.008. Epub 2009 Mar 31.
3
Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
Gastroenterology. 2009 Apr;136(4):1423-34. doi: 10.1053/j.gastro.2008.12.064. Epub 2009 Jan 6.
6
Oxidative and nitrosative stress and fibrogenic response.
Clin Liver Dis. 2008 Nov;12(4):769-90, viii. doi: 10.1016/j.cld.2008.07.005.
7
The phagocytes: neutrophils and monocytes.
Blood. 2008 Aug 15;112(4):935-45. doi: 10.1182/blood-2007-12-077917.
8
Visceral fat: a key mediator of steatohepatitis in metabolic liver disease.
Hepatology. 2008 Aug;48(2):449-57. doi: 10.1002/hep.22350.
9
Mechanisms of hepatic fibrogenesis.
Gastroenterology. 2008 May;134(6):1655-69. doi: 10.1053/j.gastro.2008.03.003.
10
Fibrogenesis of parenchymal organs.
Proc Am Thorac Soc. 2008 Apr 15;5(3):338-42. doi: 10.1513/pats.200711-168DR.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验